A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Pfizer
Stanford University
Dartmouth-Hitchcock Medical Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
NYU Langone Health
Case Comprehensive Cancer Center
FeRx